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Abstract
Introduction: To the best of our knowledge, soft tissue sarcomas have not prevously been reported as a
complication during pregnancy.
Case presentation: A 28-year-old Caucasian woman was diagnosed with a transperitoneal sarcoma during
pregnancy. Morphological, immunohistochemical, chromosomal and mutational analyses pointed towards a high-
grade endometrial stromal sarcoma. Although surgery and chemotherapy are possible during pregnancy, we were
unable to perform these in this case.
Conclusion: The potential to treat gynecological cancer during pregnancy should always be assessed individually.
Introduction
Recent literature shows an increased interest in cancer
complicating pregnancy. This is a result of the realiza-
tion that oncological treatment modalities, including
surgery and chemotherapy, can be applied after the first
gestational trimester without hampering the fetus [1,2].
Evidence from western countries shows that mainly
breast cancer and hematological malignancies are diag-
nosed during pregnancy [3]. Gynecological cancers also
significantly contribute to the problem. Cancer of the
cervix is the second most common cancer among
women worldwide and the most common gynecological
cancer in the developing world [4]. Incidence rates of
cancer complicating pregnancy therefore vary around
the world. Especially with this perspective in mind,
guidelines for the treatment of gynaecological cancer
were recently proposed [5]. In contrast, sarcomas are
uncommon and increase with age. Apart from bone sar-
comas, we are not aware of other sarcomas complicating
pregnancy. Here, we describe a fatal case of a high-grade
endometrial stromal sarcoma (ESS) diagnosed at a gesta-
tional age of 19 weeks.
Case presentation
A 28-year-old Caucasian woman consulted her gynecol-
o g i s tw i t hp a i ni nt h er i g h tf ossa at a gestational age of
15 weeks. Her medical history was straightforward. She
smoked 10 cigarettes per day for more than 10 years.
Sonographic examination suggested an appendicular
plastron and was interpreted as an ovarian mass. Subse-
quently, a laparoscopy was performed in a district hospi-
tal. Due to the pregnancy and the adhesions the view
was incomplete (the uterus and ovaries could not clearly
be identified) but peritoneal spread of malignant plaques
was evident. Microscopic examination of the peritoneal
lesions showed a solid, fat-infiltrating mass, composed
of cancerous cells with storiform growth pattern. Cancer
cells have a spindle form containing a moderate quantity
of eosinofilic cytoplasm and a polymorph vesicular
nucleus, sometimes containing a prominent nucleolus.
More than 10 mitotic figures per 10 high-power fields
were present, including abnormal mitotic figures. This
morphology corresponds to a high grade sarcoma.
Immunohistochemistry was performed and the tumor
cells revealed the following immunophenotype: desmin
(-), alpha SMA (+++), CK7 (+), CK20 (-), CD117/C-Kit
(-), S100 (-), CD34 (-), C125 (-), EMA (-), CD10 (diffuse
+ + + ) ,c a l r e t i n i n e( - ) ,C K5 . 6( - ) ,M D M2( - ) ,E R( - ) ,P R
(-). The positive staining for CD10 and alpha-smooth
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expression may be indicative for a sarcoma of endome-
trial stromal origin.
Chromosome preparations from the tumor specimen
were obtained using standard primary culture proce-
dures. For diagnostic purposes the karyotype was
determined:
66-71<3N>,XXX,+X,-1,der(2)t(1;2)(p35;q37)),-7,+11,-
13,-14,der(14;15)(q10;q10),-15,-16,+17,der(18)t(7;18)(q11;
q23),+20,+21,+21 [cp17]. Hence, the tumor karyotype
was not specific for any known translocation-related or
other sarcomas.
In order to exclude the possibility of KIT-immunone-
gative gastrointestinal stromal tumor, mutational ana-
lyses were performed using a combination of
polymerase chain reaction (PCR) amplification, denatur-
ing high-performance liquid chromatography (D-HPLC)
pre-screening, and bi-directional sequencing, as
described previously [6]. Tumor specimen showed wild-
type genotype for exons 9, 11, 13, 17 of the KIT or
exons 12, 14 and 18 of PDGFRA genes. Thus, the muta-
tional analysis was not indicative for any particular
sarcoma. Therefore, the final diagnosis was most sugges-
tive for high-grade ESS.
Subsequently, she was transferred to our hospital.
Magnetic resonance imaging showed diffuse peritoneal
and omental tumoral implants, spreading along the visc-
eral surfaces of the small bowel and large bowel, without
a definable primary mass (Figure 1). Also a moderate
amount of ascites was present. There were no signs of
hepatic and lymph node metastasis. Computer tomogra-
phy of the lungs excluded metastasis.
We discussed the diagnosis of a high-grade ESS with
transperitoneal spread, but without distant metastasis,
with the patient and her husband. Psychological support
was provided. We explained that the situation was life
threatening for both the mother and fetus. Given the
young age of the patient and expected limited response
to chemotherapy, we opted for a maximal surgical effort
during cytoreductive surgery. If this had been a case of
a significant cytoreduction, we would have considered
anthracyclin based chemotherapy, even in the presence
of an ongoing pregnancy. We agreed that if the mater-
nal situation seemed prospectless, termination of
Figure 1 Magnetic resonance imaging findings of diffuse peritoneal involvement by a poorly differentiated sarcoma.S a g i t t a lT 2 -
weighted turbo spin-echo magnetic resonance image (repetition time msec/echo time msec = 8440/136) shows diffuse sheetlike and nodular
thickening of the peritoneal surfaces (arrows). Note also a moderate amount of ascites (asterisk). Bladder (B).
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omy would appear to be a better solution when com-
pared to induction and labor. At midline laparotomy,
the tumor was diffusely spread throughout the pelvis
and upper abdomen. The disease at the level of the
peritoneum was infiltrating the sub-peritoneal fat and
this infiltration was responsible for the pain at the right
fossa. The uterine serosa was diffusely involved
(Figure 2). The small and large bowel and the omentum
contained diffuse and multiple tumoral plaques. Given
the diffuse and sometimes deep infiltration of both the
peritoneum and intestines, she was considered inoper-
able. A hysterotomy was performed, leaving the uterus
in situ. The placenta was macroscopically and microsco-
pically normal. Three days later, intestinal obstruction
was diagnosed. We agreed that chemotherapy was not
likely to be a clinical benefit for a high-grade sarcoma
causing intestinal obstruction whereas the potential for
sepsis was considerable. Symptomatic treatment was
initiated. She died at home six weeks after diagnosis.
Discussion
To the best of our knowledge, this is the first case of a
transperitoneal high-grade ESS complicating pregnancy.
Despite our policy to explore all possibilities in order to
maintain the pregnancy, we were unable to save the
fetus.
After diagnostic work-up, we agreed that the tumor
resembled a high-grade ESS. However, this designation
should be used cautiously. Most previously so-called
high-grade tumors lack the typical growth pattern and
vascularity of low-grade ESS and show destructive myo-
metrial invasion rather than the lymphatic permeation
of a low-grade ESS. Moreover, they demonstrate marked
cellular pleomorphism and brisk mitotic activity.
Tumours that used to be termed high-grade ESS are
currently called poorly differentiated or undifferentiated
uterine sarcoma [7,8]. Occasional tumors as the one
described here have been reported that are high-grade
and of endometrial stromal derivation [7]. Although we
were unable to examine the uterus and confirm this
diagnosis, the combination of morphological, immuno-
histochemical, chromosomal and a mutational analysis
suggests high-grade ESS. We emphasise that some
would call this an undifferentiated sarcoma. Based on
t h ea b s e n c eo fh o r m o n er e c e p t o r s ,w ed on o tb e l i e v e
that hormonal stimulation during pregnancy has a role
in the origin of the sarcoma. Cancers complicating preg-
nancy reflect the young age of the mother rather than
an etiologic role of pregnancy.
In order to treat the patient and preserve the preg-
nancy, we considered major surgery and chemotherapy.
Laparoscopy and explorative surgery were performed in
this patient. Laparoscopy can be performed safely in
experienced hands and has the same advantages as in
non-pregnant women [9-11]. The carbon dioxide pneu-
moperitoneum and carbon monoxide production during
electro-coagulation seems not to be hazardous to the
fetus as long as the maximal pressure (13-15 mmHg)
and operation time (25-90 minutes) are respected. Open
laparoscopy (opening of the peritoneum under direct
visualisation instead of using the Verres-needle) is
advised in order to avoid uterine perforation. Abdominal
surgery can be performed safely during pregnancy if
physiologic adaptations are considered and the patient is
monitored adequately, preventing hypoxia, hypotension
and hypoglycemia [12]. Outcome data described in lit-
erature suggest there is no increased risk of miscarriage
and congenital anomalies. Only in cases of peritonitis is
the fetal loss rate increased [13]. Apart from urgent sur-
gery, including appendectomy and cholecystectomy,
oncological surgery can also be performed. We based
our decision to attempt to cytoreduce the patient on
previous successful experience including debulking sur-
gery with preservation of the pregnancy for advanced
stage ovarian cancer [14,15].
Chemotherapy can be administered in the second and
third trimester of pregnancy, after organogenesis [1].
Anthracyclines have a particular efficacy against sarco-
mas. From previous experience in breast cancer and
hematological malignancies occurring during pregnancy,
there is considerable evidence on the safety of anthracy-
clines on the fetus [1,2].
We opted for an exploratory laparotomy to remove
the tumor. However, the operative findings proved
untenable given the diffuse and deep infiltration of the
abdominal wall and small bowel and colon. The decision
to terminate the pregnancy was based on the extensive
transperitoneal spread of a high-grade sarcoma, the lim-
ited sensitivity of sarcomas to cytotoxic drugs and the
diffuse uterine involvement. This situation would not
Figure 2 Peroperative findings indicating diffuse tumoral
infiltration of the uterine serosa.
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preoperatively with the parents and allowed us to surgi-
cally remove the pregnancy by hysterotomy rather than
bring her to labor ward for a prostaglandin induction.
Conclusion
This case shows that loss of pregnancy may be inevita-
ble, despite the theoretical potential to perform major
surgery and to administer chemotherapy during preg-
nancy. The treatment of gynecological cancer during
pregnancy is case dependent.
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